8:01 am Agios Pharma initiates phase 1 study of aG-348 for Pyruvate kinase deficiency
View todays social media effects on AGIO
View the latest stocks trending across Twitter. Click to view dashboard
See who Agios is hiring next, click here to view
21
Apr
